Latest Breaking News On - Tarun upadhyay - Page 10 : vimarsana.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Neenab haiderTarun upadhyayShankar musunuriRetina foundation of theHead of communicationsHead of clinical developmentExchange commissionOcugen incHead of researchAnalyst eventChief scientific officerClinical developmentMedical affairsScientific directorRetina foundationConference call

Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress

MALVERN, Pa., March 31, 2023 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today. | March 31, 2023

United statesTarun upadhyayWorld vaccine congressExchange commissionWaltere washington convention centerOcugen incChief scientific officerConvention centerPrivate securities litigation reform actNc stock exchangePress releaseNd ocgn us67577c1053

Ocugen Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)

U.S. Food & Drug Administration approves enrolling pediatric patients in the ongoing OCU400 Phase 1/2 trial who have: 1) RP associated with NR2E3 and RHO mutations and 2) LCA associated with. | March 27, 2023

United statesTarun upadhyayUs food drug administrationNuclear hormone receptors nhrsOcugen incExchange commissionDrug administrationChief scientificNuclear hormone receptorsPrivate securities litigation reform actNc stock exchangePress releaseSsociated ocgn us67577c1053

Ocugen (OCGN) Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial

Ocugen (OCGN) Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTarun upadhyayOcugen incHead of communicationsExchange commissionNuclear hormone receptors nhrsWall streetChief scientificNuclear hormone receptorsPrivate securities litigation reform act

Ocugen (OCGN) Submits iNDA to Initiate a Phase 1 Trial of OCU200

Ocugen (OCGN) Submits iNDA to Initiate a Phase 1 Trial of OCU200
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTarun upadhyayHead of communicationsDrug administrationOcugen incExchange commissionWall streetInvestigational new drugChief scientific officerPrivate securities litigation reform act